178 related articles for article (PubMed ID: 11698073)
1. Regulation of immunoglobulin E-mediated secretion by protein phosphatases in human basophils and mast cells of skin and lung.
Bastan R; Peirce MJ; Peachell PT
Eur J Pharmacol; 2001 Oct; 430(1):135-41. PubMed ID: 11698073
[TBL] [Abstract][Full Text] [Related]
2. Characterization of protein serine/threonine phosphatase activities in human lung mast cells and basophils.
Peirce MJ; Munday MR; Peachell PT
Br J Pharmacol; 1998 Nov; 125(5):1095-101. PubMed ID: 9846650
[TBL] [Abstract][Full Text] [Related]
3. Preliminary characterization of the role of protein serine/threonine phosphatases in the regulation of human lung mast cell function.
Peirce MJ; Cox SE; Munday MR; Peachell PT
Br J Pharmacol; 1997 Jan; 120(2):239-46. PubMed ID: 9117116
[TBL] [Abstract][Full Text] [Related]
4. Regulation of human basophil function by phosphatase inhibitors.
Peirce MJ; Warner JA; Munday MR; Peachell PT
Br J Pharmacol; 1996 Sep; 119(2):446-53. PubMed ID: 8886433
[TBL] [Abstract][Full Text] [Related]
5. Regulation of human lung mast cell function by phosphatase inhibitors.
Peachell PT; Munday MR
J Immunol; 1993 Oct; 151(7):3808-16. PubMed ID: 7690815
[TBL] [Abstract][Full Text] [Related]
6. Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin.
Favre B; Turowski P; Hemmings BA
J Biol Chem; 1997 May; 272(21):13856-63. PubMed ID: 9153244
[TBL] [Abstract][Full Text] [Related]
7. Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases.
Honkanen RE; Codispoti BA; Tse K; Boynton AL; Honkanan RE
Toxicon; 1994 Mar; 32(3):339-50. PubMed ID: 8016855
[TBL] [Abstract][Full Text] [Related]
8. Effect of inhibitors of protein phosphatase 1 and 2A on erythroid colony formation: an investigation of the specificities of inhibitors.
Zhang W; Tamura J; Sakuraya M; Naruse T; Kubota K
J Int Med Res; 2001; 29(2):114-8. PubMed ID: 11393344
[TBL] [Abstract][Full Text] [Related]
9. Importance of the beta12-beta13 loop in protein phosphatase-1 catalytic subunit for inhibition by toxins and mammalian protein inhibitors.
Connor JH; Kleeman T; Barik S; Honkanen RE; Shenolikar S
J Biol Chem; 1999 Aug; 274(32):22366-72. PubMed ID: 10428807
[TBL] [Abstract][Full Text] [Related]
10. Role of phosphoprotein phosphatases in the corpus luteum: I identification and characterisation of serine/threonine phosphoprotein phosphatases in isolated rat luteal cells.
Ford SL; Abayasekara DR; Persaud SJ; Jones PM
J Endocrinol; 1996 Aug; 150(2):205-11. PubMed ID: 8869587
[TBL] [Abstract][Full Text] [Related]
11. [Naturally occurring toxins with specific inhibitory activity against protein serine/threonine phosphatases 1 and 2A].
Takai A
Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1091-101. PubMed ID: 9655967
[No Abstract] [Full Text] [Related]
12. Inhibitors of protein phosphatases 1 and 2A differentially prevent intrinsic and extrinsic apoptosis pathways.
Chatfield K; Eastman A
Biochem Biophys Res Commun; 2004 Oct; 323(4):1313-20. PubMed ID: 15451440
[TBL] [Abstract][Full Text] [Related]
13. Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A.
Walsh AH; Cheng A; Honkanen RE
FEBS Lett; 1997 Oct; 416(3):230-4. PubMed ID: 9373158
[TBL] [Abstract][Full Text] [Related]
14. Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
McCluskey A; Sim AT; Sakoff JA
J Med Chem; 2002 Mar; 45(6):1151-75. PubMed ID: 11881984
[No Abstract] [Full Text] [Related]
15. Distinct roles for PP1 and PP2A in phosphorylation of the retinoblastoma protein. PP2a regulates the activities of G(1) cyclin-dependent kinases.
Yan Y; Mumby MC
J Biol Chem; 1999 Nov; 274(45):31917-24. PubMed ID: 10542219
[TBL] [Abstract][Full Text] [Related]
16. Role of protein phosphatases in cyclic AMP-mediated stimulation of hepatic Na+/taurocholate cotransport.
Mukhopadhyay S; Webster CR; Anwer MS
J Biol Chem; 1998 Nov; 273(45):30039-45. PubMed ID: 9792726
[TBL] [Abstract][Full Text] [Related]
17. Effects of fostriecin on β2-adrenoceptor-driven responses in human mast cells.
Bastan R; Eskandari N; J Ardakani H; T Peachell P
J Immunotoxicol; 2017 Dec; 14(1):60-65. PubMed ID: 28090813
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors.
Swingle MR; Amable L; Lawhorn BG; Buck SB; Burke CP; Ratti P; Fischer KL; Boger DL; Honkanen RE
J Pharmacol Exp Ther; 2009 Oct; 331(1):45-53. PubMed ID: 19592665
[TBL] [Abstract][Full Text] [Related]
19. Effect of okadaic acid on immunologic and non-immunologic histamine release in rat mast cells.
Estévez MD; Vieytes MR; Louzao MC; Botana LM
Biochem Pharmacol; 1994 Feb; 47(3):591-3. PubMed ID: 8117330
[TBL] [Abstract][Full Text] [Related]
20. The effect of okadaic acid on histamine release, cell morphology and phosphorylation in rat basophilic leukemia (RBL-2H3) cells, human basophils and rat peritoneal mast cells.
Kitani S; Teshima R; Nonomura Y; Morita Y; Ito K
Int Arch Allergy Immunol; 1996 Aug; 110(4):339-47. PubMed ID: 8768801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
